Search results for " Product"

showing 10 items of 7368 documents

Pediatric non-red cell blood product transfusion practices: what's the evidence to guide transfusion of the ‘yellow’ blood products?

2020

Purpose of review Research studies pertaining to the management of pediatric non-red cell blood product transfusion is limited. Clinical practices vary within disciplines and regions. Anesthesiologists need evidence-based guidelines to make appropriate and safe decisions regarding transfusion of the 'yellow' blood products for pediatric patients. Recent findings This review outlines clinical indications for transfusion of fresh frozen plasma, cryoprecipitate, platelets, and fibrinogen concentrate in pediatrics. Recent studies of non-red blood cell transfusions in critical, but stable situations are highlighted. Recommendations to guide transfusion of the 'yellow' blood products in operative…

medicine.medical_specialtyRed Cellbusiness.industryMEDLINE030204 cardiovascular system & hematologyFibrinogenBlood cell03 medical and health sciences0302 clinical medicineAnesthesiology and Pain Medicinemedicine.anatomical_structureBlood productCryoprecipitatemedicinePlatelet030212 general & internal medicineFresh frozen plasmaIntensive care medicinebusinessmedicine.drugCurrent Opinion in Anaesthesiology
researchProduct

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

2014

Many placebo controlled trials and meta-analyses evaluated the efficacy of different drugs for the treatment of inflammatory bowel disease (IBD), including immunosuppressants and biologics. Their use is indicated in moderate to severe disease in non responders to corticosteroids and in steroid-dependent patients, as induction and maintainance treatment. Infliximab, as well as cyclosporine, is considered a second line therapy in the case of severe ulcerative colitis, or non-responders to intravenous corticosteroids. An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. Methotrexate is a valid option in patients with Crohn’s disease bu…

medicine.medical_specialtySettore MED/09 - Medicina InternaCombination therapyInflammatory bowel diseaseGastroenterologyimmunosuppresantbiologicsinflammatory bowel diseaseCrohn DiseaseGastrointestinal AgentsRisk FactorsInternal medicinemedicineimmunomodulators.optimization. treatmentHumansTopic HighlightBiological ProductsGastrointestinal agentCrohn's diseaseThiopurine methyltransferasebiologybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisTacrolimusInfliximabSurgeryTreatment Outcomebiology.proteinColitis UlcerativeDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Online Adaptation to Altered Auditory Feedback Is Predicted by Auditory Acuity and Not by Domain-General Executive Control Resources

2018

Published: 12 March 2018 When a speaker's auditory feedback is altered, he adapts for the perturbation by altering his own production, which demonstrates the role of auditory feedback in speech motor control. In the present study, we explored the role of auditory acuity and executive control in this process. Based on the DIVA model and the major cognitive control models, we expected that higher auditory acuity, and better executive control skills would predict larger adaptation to the alteration. Thirty-six Spanish native speakers performed an altered auditory feedback experiment, executive control (numerical Stroop, Simon and Flanker) tasks, and auditory acuity tasks (loudness, pitch, and …

medicine.medical_specialtySpeech productionauditory acuityspeech productionadaptationAudiologyta311201 natural sciences050105 experimental psychologylcsh:RC321-571LoudnessBehavioral Neurosciencepuheentuotto0103 physical sciencesOnline adaptationmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. Neuropsychiatry010301 acousticsaltered feedbackBiological PsychiatryOriginal ResearchAuditory acuityAuditory feedbackpalaute05 social sciencesCognitionPseudowordPsychiatry and Mental healthexecutive controlNeuropsychology and Physiological PsychologyNeurologyPsychologyNeuroscienceStroop effectFrontiers in Human Neuroscience
researchProduct

Imaging of Ventriculoperitoneal Shunt Complications: Comparison of Whole Body Low-Dose Computed Tomography and Radiographic Shunt Series.

2016

OBJECTIVE To determine diagnostic value and radiation exposure of low-dose computed tomography (LD-CT) compared to radiographic shunt series (SS) for the detection of ventriculoperitoneal (VP) shunt complications. METHODS Fourteen VP shunts were implanted in 7 swine cadavers. Mechanical complications were induced in 50% of VP shunts. Low-dose CT (80 kVp, 10 mAs, Pitch = 1.5) and SS were acquired. Dose area product (DAP) and effective doses for SS and LD-CT were collected. Scoring of diagnostic confidence and blinded readings of SS and CT data were performed. RESULTS The sensitivity of LD-CT was high (0.97; 95% confidence interval, 0.91-1.00) with excellent interobserver agreement (κ = 0.88)…

medicine.medical_specialtySwineRadiographyComputed tomographyRadiation DosageEffective dose (radiation)Sensitivity and SpecificityVentriculoperitoneal Shunt030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRadiation ProtectionmedicineAnimalsRadiology Nuclear Medicine and imagingMedical physicsSingle-Blind MethodWhole Body Imagingmedicine.diagnostic_testbusiness.industryLow doseReproducibility of ResultsRadiation ExposureConfidence intervalRadiographic Image EnhancementDose area productRadiographic Image Interpretation Computer-AssistedTomographybusinessNuclear medicineTomography X-Ray Computed030217 neurology & neurosurgeryShunt (electrical)Journal of computer assisted tomography
researchProduct

Optimal savings and health spending over the life cycle

2010

This paper investigates the relationship between saving and health spending in a two-period overlapping generations economy. Individuals work in the first period of life and live in retirement in old age. Health spending is an activity that increases quality of life and longevity. Empirical evidence shows that both health spending and saving behave as luxury goods but their behaviour differs markedly according to the level of per capita GDP. The share of saving on GDP has a concave shape with respect to per capita GDP, whereas the share of health spending on GDP increases more than proportionally with respect to per capita GDP. The ratio of saving to spending is nonlinear with respect to in…

medicine.medical_specialtyTime FactorsHealth spendingEconomics Econometrics and Finance (miscellaneous)Decision MakingIntertemporal choiceOverlapping generations modelIntertemporal choiceGross domestic productStatistics NonparametricResource AllocationMicroeconomicsCost SavingsEconomicsmedicineHumansEmpirical evidenceSettore SECS-P/01 - Economia Politicahealth care economics and organizationsHealth economicsModels StatisticalAdult mortalitySavingPublic healthHealth PolicyModels EconomicReal gross domestic productItalyQuality of LifeHealth ResourcesDemographic economicsIntertemporal choice; Health spending; Adult mortality; SavingHealth ExpendituresPublic finance
researchProduct

D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism

2007

Patients with suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) are frequently admitted to an Emergency Department (ED) for initial evaluation. However, management of patients with suspicion of acute venous thromboembolism (VTE) in this clinical setting can be difficult; in fact symptoms and signs of DVT are non-specific and can be found in a broad spectrum of non-thrombotic disorders. An accurate and timely objective diagnosis is necessary for immediate and correct identification of patients with acute VTE, while avoiding the bleeding risk associated with unnecessary anticoagulant therapy in patients where DVT or PE have been ruled out. The diagnostic approach to patients wit…

medicine.medical_specialtyTime FactorsMEDLINEEnzyme-Linked Immunosorbent AssayEnglish languageDiseaseSensitivity and SpecificityFibrin Fibrinogen Degradation ProductsNephelometry and TurbidimetryD-dimermedicineInternal MedicineHumanscardiovascular diseasesProspective cohort studyLetters to the EditorIntensive care medicinePathologicalVenous ThrombosisPregnancybusiness.industryClinical judgementData synthesisEmergency departmentmedicine.diseasePulmonary embolismD-dimer emergency medicine venous thromboembolismVenous thrombosisAcute DiseaseEmergency medicineEmergency MedicineEmergenciesbusinessVenous thromboembolismAlgorithmsBlood samplingInternal and Emergency Medicine
researchProduct

Radiation exposure in vascular angiographic procedures.

2012

Abstract Purpose To evaluate dose reduction in vascular angiographic procedures by using fluoroscopy capture instead of digital subtraction angiography frames for documentation. Materials and Methods A total of 764 consecutive vascular interventional procedures performed over a period of 1 year were retrospectively analyzed with respect to the fluoroscopy time and the resulting dose–area product (DAP), the DAP of the radiographic frames, and the overall DAP. Results A total of 70% of the total DAP was a result of the acquisition of radiographic frames, leaving only 30% being applied by fluoroscopy. Conclusions Fluoroscopy capture should be used for documentation whenever possible. A registr…

medicine.medical_specialtyTime FactorsRadiographyHealth PersonnelRadiation DosageRadiography InterventionalRadiation ProtectionRadiation MonitoringOccupational ExposuremedicineFluoroscopyHumansRadiology Nuclear Medicine and imagingOccupational HealthRetrospective Studiesmedicine.diagnostic_testbusiness.industryAngiography Digital SubtractionDigital subtraction angiographyRadiation exposureDose area productFluoroscopyDose reductionRadiologyCardiology and Cardiovascular MedicinebusinessNuclear medicineJournal of vascular and interventional radiology : JVIR
researchProduct

How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?

2009

The current approach for deciding the duration of vitamin K antagonist (VKA) treatment after an episode of venous thrombo-embolism (VTE) is mainly based on the characteristic of the index event (3 months or longer in case of unknown/persistent risk factors, 3 months or less in case of removable causes). However, the length of anticoagulation should be tailored on the patient's risk for recurrent thrombosis as well as for bleeding, but such 'time for decision' is often unclear and the optimal duration of VKA remains debatable. The presence of persistent residual vein thrombosis and increased D-dimer levels after stopping therapy are predictors for recurrent deep vein thrombosis (DVT). Manage…

medicine.medical_specialtyTime FactorsVitamin Kmedicine.drug_classDeep veinRisk AssessmentDrug Administration ScheduleRecurrent deep vein thrombosisSettore MED/15 - Malattie Del SangueFibrin Fibrinogen Degradation ProductsFibrinolytic AgentsRecurrenceNeoplasmsmedicineHumansVenous ThrombosisFirst episodebusiness.industryVascular diseaseAnticoagulantVitaminsHematologyVitamin K antagonistmedicine.diseaseThrombosisduration anticoagulants venous thromboembolismSurgeryVenous thrombosismedicine.anatomical_structurebusinessBiomarkersBritish Journal of Haematology
researchProduct

Progestogens reduce thromboxane production by cultured human endothelial cells.

2011

Objectives Progestogens have been poorly studied concerning their roles in endothelial physiology. Prostanoids are vasoactive compounds, such as thromboxane A2, a potent vasoconstrictor, and prostacyclin, a vasodilator. We examined the effects of two progestogens used clinically, progesterone and medroxyprogesterone acetate, on thromboxane A2 production by cultured human umbilical vein endothelial cells (HUVEC) and investigated the role of progesterone receptors and the enzymes involved in production of thromboxane A2 and prostacyclin. Methods Cells were exposed to 1‐100 nmol/l of either progesterone or medroxyprogesterone acetate, and thromboxane A2 production was measured in culture mediu…

medicine.medical_specialtyUmbilical VeinsAntineoplastic Agents HormonalThromboxaneBlotting WesternGene ExpressionProstacyclinMedroxyprogesterone AcetatePolymerase Chain ReactionProstacyclin synthaseThromboxane receptorThromboxane ProductionThromboxane A2chemistry.chemical_compoundThromboxane A2Hormone AntagonistsCytochrome P-450 Enzyme SystemInternal medicineProgesterone receptorMedicineHumansCyclooxygenase InhibitorsRNA MessengerCells CulturedProgesteronebiologyDose-Response Relationship Drugbusiness.industryObstetrics and GynecologyEndothelial CellsGeneral MedicineIntramolecular OxidoreductasesThromboxane B2MifepristoneEndocrinologychemistrycardiovascular systembiology.proteinPyrazolesThromboxane-A synthaseThromboxane-A SynthaseProgestinsbusinessmedicine.drugClimacteric : the journal of the International Menopause Society
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct